Table 1.
Series | Total cases | MCD | FSGS | PGN (immune mediated GN) |
---|---|---|---|---|
Markowitz et al. [3] | 19 | 2 (11%) | 17 (89%) | 0 |
Fukuma et al. (children) [14] | 30 | 22 (73%) | 2 (7%) | 6 (20%) |
Hisano et al. [15] | 61 | 46 (75%) | 8 (13%) | 7 (11%) |
Vizjak et al. [10] | 72 | 27 (38%) | 11 (16%) | 20 (28%) |
Gunasekara et al. (children) [4] | 35 | 19 (54%) | 9 (26%) | 7 (20%) |
Said et al. (allografts) [13] | 24 | 8 (33%) | 5 (21%) | 11 (46%) |